Vigonvita Life Sciences Co., Ltd. (HKG:2630)
75.20
+2.35 (3.23%)
Nov 17, 2026, 4:08 PM HKT
Vigonvita Life Sciences Market Cap
Vigonvita Life Sciences has a market cap or net worth of 12.6 billion as of November 16, 2026. It is the 7,542nd most valuable company in the world and the 372nd biggest in Hong Kong. Its market cap has increased by 10.26% in one year.
Market Cap
12.60B
Enterprise Value
13.11B
Revenue
250.82M
Global Rank
Country Rank
#372 Hong Kong
PE Ratio
n/a
ChartMarket Cap Chart
Since November 6, 2025, Vigonvita Life Sciences's market cap has decreased from 13.74B to 12.60B, a decrease of -8.29%. That is a compound annual growth rate of -8.06%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 17, 2026 | 12.60B | -8.12% |
| Dec 31, 2025 | 13.72B | -0.18% |
| Nov 6, 2025 | 13.74B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 373.29B |
| Hansoh Pharmaceutical Group Company | 208.68B |
| WuXi Biologics | 191.81B |
| Innovent Biologics | 147.54B |
| Angelalign Technology | 13.53B |
| Consun Pharmaceutical Group | 13.22B |
| CanSino Biologics | 12.31B |
| Fujian Haixi Pharmaceuticals | 12.28B |